VanEck Pharmaceutical ETF
PPH
PPH
139 hedge funds and large institutions have $441M invested in VanEck Pharmaceutical ETF in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 34 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3.6% less ownership
Funds ownership: 77.39% → 73.79% (-3.6%)
76% less call options, than puts
Call options by funds: $977K | Put options by funds: $4.03M
Holders
139
Holding in Top 10
1
Calls
$977K
Puts
$4.03M
Top Buyers
| 1 | +$15.7M | |
| 2 | +$13.4M | |
| 3 | +$8.93M | |
| 4 |
FPGK
Financial Partners Group (Kansas)
Overland Park,
Kansas
|
+$8.49M |
| 5 |
BC
Bricktown Capital
Detroit,
Michigan
|
+$5.76M |
Top Sellers
| 1 | -$28.5M | |
| 2 | -$6.31M | |
| 3 | -$4.75M | |
| 4 |
GIA
Gladstone Institutional Advisory
Palm Beach Gardens,
Florida
|
-$3.72M |
| 5 |
Jane Street
New York
|
-$2.34M |